HD vs KOD: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HD and KOD share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HD and KOD exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

The Home Depot, Inc. is the world's largest home improvement retailer, operating approximately 2,300 stores across the United States, Canada, and other locations in North America. The company sells building materials, home improvement products, lawn and garden supplies, and provides installation and tool-rental services to two main customer groups: do-it-yourself homeowners (DIY) and professional contractors (Pros). Revenue is generated almost entirely through retail store sales and, increasingly, through digital channels (online sales reached 15.9% of total revenue in fiscal 2025) and through its specialty trade distribution arm, SRS Distribution, which serves Pros directly with roofing, landscaping, pool supplies, and now drywall and steel framing products following the September 2025 acquisition of GMS Inc. The company earns a gross margin of roughly 33% and an operating margin in the low-to-mid teens, with strong free cash flow that funds a steadily growing dividend (156 consecutive quarterly payments as of early 2026) and periodic share repurchases.

Full HD guide

Kodiak Sciences is a Palo Alto based biotechnology company developing therapies for high-prevalence retinal diseases such as diabetic retinopathy, wet age-related macular degeneration (wet AMD), and macular edema. Its programs are built on an antibody biopolymer conjugate (ABC) platform intended to extend how long a single injection lasts in the eye. The lead candidate, tarcocimab tedromer (branded Zenkuda), delivered positive Phase 3 GLOW2 data in diabetic retinopathy in early 2026, while additional Phase 3 studies (DAYBREAK in wet AMD with KSI-501, and PEAK and PINNACLE for KSI-101 in macular edema secondary to inflammation) are reading out into 2027.

Full KOD guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• HD drivers: Pro contractor ecosystem buildout; Pent-up housing demand and a potential mortgage rate cycle turn.
• KOD drivers: Multi-indication Phase 3 pipeline; Durability-focused ABC platform.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most direct risk is a prolonged freeze in the US housing market: low inventory, elevated mortgage rates, and high home prices have kept transaction volumes near multi-decade lows, directly suppressing demand for the large remodeling projects that drive Home Depot's highest-ticket sales. For KOD, as a pre-revenue clinical-stage biotech, Kodiak is exposed to binary trial risk, and a single failed Phase 3 readout can move the stock sharply, as the 2021 wet AMD failure demonstrated.

Pick HD if you believe its drivers more; KOD if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HD and KOD guides.

HD. Home Depot grew total revenue 3.2% in fiscal 2025, but most of that growth came from the SRS and GMS acquisitions rather than organic comparable-store performance, which was essentially flat at +0.3%. Profitability softened modestly as acquisition-related costs, higher debt service, and integration expenses weighed on margins and pushed ROIC down from 31.3% to approximately 25.7%. The stock's trailing P/E of roughly 23x sits near its 10-year historical average and above the peer group, reflecting investor confidence in the long-term Pro strategy but leaving limited cushion if the housing market remains depressed longer than expected.

KOD. Kodiak has no product revenue and posts steady net losses, so traditional earnings multiples do not apply and valuation reflects pipeline expectations. Cash of roughly $170 million against a quarterly burn near $58 million supports operations into 2027, meaning further financing could be needed. The market capitalization near $1.3 billion effectively prices in the probability-weighted value of its Phase 3 programs.

Headline figures (approximate, 2026-06-27 (fiscal 2025 results as reported February 24, 2026; P/E as of June 9, 2026)): HD shows revenue (fiscal 2025, ended feb 1, 2026) ~$164.7 billion, net earnings (fiscal 2025) ~$14.2 billion, diluted eps (fiscal 2025) $14.23 (adjusted: $14.69), gross margin (fiscal 2026 guidance) ~33.1%; KOD shows revenue (ttm) ~$0 (no approved products), net loss (q1 2026) ~$58M, r&d expense (q1 2026) ~$49M, cash & equivalents (mar 2026) ~$170M.

HD and KOD are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined HD and KOD exposure against your real portfolio. It is not an investment adviser.